California Bills May Impact Industry

April 8, 2002

1 Min Read
California Bills May Impact Industry

California Bills May Impact Industry

SACREMENTO--Five bills were introduced to the California Senate pertaining to dietary supplements. SB 1948, introduced Feb. 22 by Sen. Liz Figueroa (D-Fremont), asks that warning labels be clear and conspicuous on both the product and the product's advertisement. SB 1964, introduced Feb. 22 by Sen. Dede Alpert (D-San Diego), would make it unlawful to sell any substance to persons under 18--with the exception of caffeine--that has been banned by the National Collegiate Athletic Association. This would include products containing ephedrine, androstenedione and HGH. SB 1610, introduced Feb. 21 by Sen. Debra Bowen (D-Marina del Rey), asks for disclosure of trans fatty acids present in dietary supplements manufactured and distributed in California.

Sen. Jackie Speier (D-San Francisco), a long-time pundit against ephedra supplements, introduced two bills. SB 1562, introduced Feb. 20, asks that school districts be required to instruct on the effects of using performance-enhancing substances. And SB 1750, introduced Feb. 21, asks that dietary supplements containing ephedrine alkaloids, creatine and androstenedione have labeled warnings. Also, this bill would make it a misdemeanor for any manufacturer, wholesaler or retailer to sell products with these three ingredients to minors under 18 years old. For more information about these bills, visit

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like